New York, NY, November 7, 2024 – NMS Capital (“NMS”), a leading private equity firm focused on investments within subsectors of Healthcare Services and Business Services, today announced that it has exited its investment in Flourish Research (“Flourish” or the “Company”) through a sale to Genstar Capital (“Genstar”). NMS formed Flourish, a leading multi-site clinical […]
New York, NY, June 25, 2024 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with ENCORE™ Research Group (“ENCORE” or the “Company”). ENCORE™ is a leading clinical research organization with eight locations across Northern Florida. With 100+ investigators, ENCORE™ brings expertise across multiple therapeutic areas including cardiology, metabolic, […]
New York, NY, November 14, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with Merritt Island Medical Research (“MIMR” or the “Company”). MIMR is a leading clinical research site located in Merritt Island, Florida that specializes in neuroscience related indications including Alzheimer’s Disease. The partnership represents the […]
New York, NY, September 15, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Valley Clinical Trials (“Valley” or the “Company”). Valley is a leading clinical research site with three locations in California that specialize in cardiology, metabolic, and related therapeutic areas. The partnership represents the ninth acquisition since […]
New York, NY, May 18, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish” or the “Company”) announced today that it has partnered with company management in the recapitalizations of AMC Research, LLC (“AMC”) and Central Research Associates (“CRA”), which are both leading clinical research sites that further establish Flourish as one of the […]
New York, NY, December 16, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Suncoast Research Group, LLC (“Suncoast” or the “Company”). Suncoast is a leading, multi-therapeutic clinical research site based in Miami, Florida. The transaction marks the sixth investment and partnership for Flourish Research, which was […]
New York, NY, October 6, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with company management in the recapitalization of Keystone Clinical Studies, LLC (“Keystone”). Keystone is a leading clinical research site focused on Alzheimer’s Disease and other conditions related to the Central Nervous System. The site […]
New York, NY, January 12, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish” or the “Company”) announced today that it has partnered with company management in the recapitalizations of Great Lakes Clinical Trials (“Great Lakes”) and Clinical Site Partners (“CSP”), which are both leading clinical research sites. The transactions mark the third and […]
New York, NY, October 14, 2021 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with company management in the recapitalization of Excel Medical Clinical Trials, LLC (“Excel”). Excel is a leading clinical research site focused on Cardiology and related conditions serving leading pharmaceutical companies and CROs founded in […]
New York, NY, August 12, 2021 – NMS Capital (“NMS”) announced today that it has formed Flourish Research (“Flourish”), which will aim to become a leading, nationwide network of clinical research sites with therapeutic area and clinical trial phase diversity. For its initial investment in Flourish Research, NMS has completed the recapitalization of Clinical Trials […]